PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The downside of corporate dominance

The downside of corporate dominance
2012-05-18
(Press-News.org) We've said farewell to Friendster. Netscape Navigator is nevermore. As an Internet service provider, AOL is AWOL. What happened to these companies that once ruled their individual markets? According to two University of Alberta researchers, their market dominance made them vulnerable.

In a research paper recently published in MIT Sloan Management Review, University of Alberta marketing professors Kyle Murray and Gerald Häubl posit that it may only take an upstart competitor to make the mighty fall in the hearts and minds of consumers. What causes consumers to react negatively, and how the backlash could be potentially mitigated, are lessons that current market leaders (such as Google) and struggling once-dominant companies (such as Research in Motion) should learn from former market leaders.

"One of the lessons that we've seen in our research is that it's better for people if they have a choice," said Murray.

Monopoly: A fun game, but a potentially risky market position

The researchers found that if consumers are in a position where they have only one choice of a product or service, such as an airline or specific software, they will use it—but merely out of resignation. Yet, when a competitor enters the market with a good alternative, consumers will now feel they have a choice and may flood to the new product or service simply for that reason.

It may sound like mere fickleness on the part of the consumer, but the researchers say it is more about exercising freedom.

"Even though we still get really good at shopping at that store or using that interface or website, we never formed that loyalty and we want to assert our freedom to choose," said Häubl. "Eventually, when a new competitor enters the stage, we are inclined to try that and actually switch away from that incumbent."

A Mac/PC parable: It pays to invest—in the competitor?

Though success in the marketplace is generally a good thing, too much success can be the pride before the fall. As Murray notes in the paper, recognizing the need for competition or being satisfied with a cut of the market share can perhaps be a key to maintaining one's place at the top. Back in 1997, he says, Microsoft invested $150 million to keep Apple afloat. And although Windows may have the lion's share of operating system control, Apple has found its own place in the world as well, in part due to that hand up from a competitor.

"Apple has made this comeback and now they're the largest company in the world by stock valuation," he said. "People may think Apple's going to be dominant forever. [That's] unlikely. Somebody else will come along and people will start to say, 'Everybody has an iPhone, I want something different,' and we'll see some switching."

Advice for companies great and small

For the players with a large market share, reminding consumers that they have a choice is a smart strategy to employ, say the researchers. Häubl says using supportive, comparative advertising is one way to prompt customers about their choices—and remind them of why they choose the way they do. "Settle for a large market share as opposed to a dominant market share," suggests Häubl, because trying to push out a competitor will be costly and largely unsuccessful. The reverse logic applies for smaller companies, says Murray.

"Sometimes you feel like the big competitors are so dominant, there's nothing you can do to get away from them or compete," he said. "There's always a segment out there of people who want an alternative.

"The goal for a smaller company, even in the market with a dominant player, is to be that alternative as opposed to competing head-on for the exact same customers."



INFORMATION:


[Attachments] See images for this press release:
The downside of corporate dominance

ELSE PRESS RELEASES FROM THIS DATE:

Testing for mutations identified in squamous cell lung cancer tumors helps personalize treatment

2012-05-18
NEW YORK, May 16, 2012 — Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most common type of non-small cell lung cancer — and have developed drugs that can successfully address them, scientists have not yet identified targeted therapies for another type of non-small cell lung cancer known as squamous cell carcinoma. Now, researchers from Memorial ...

Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer

2012-05-18
CHICAGO, IL (May 16, 2012)––For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule. However, in an effort to improve toxicity, standard MVAC has been essentially abandoned in favor of other regimens. ...

Fox Chase researchers find no disparities in imaging before breast cancer surgery

2012-05-18
CHICAGO, IL (May 16, 2012)––If racial and ethnic disparities in breast cancer exist, they are not due to differences in the use of imaging to assess the extent of tumors before surgery, according to new findings that will be presented by Fox Chase Cancer Center researchers at the 2012 Annual Meeting of the American Society of Clinical Oncology on Monday, June 4. "It's encouraging that we didn't see any differences between black and white women in the use of imaging before surgery," says lead study author Richard J. Bleicher, M.D., a breast surgeon at Fox Chase. There ...

More cutting-edge cancer research supported by industry

2012-05-18
CHICAGO, IL (May 16, 2012)––Nearly half of the research presented at ASCO's annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. The new findings will be presented this year at the 2012 American Society of Clinical Oncology Annual Meeting on Monday, June 4. "The results suggest that there may be an increasing dependence on industry to support cancer research," says study author Angela R. Bradbury, M.D., assistant professor in the Department of ...

UCLA researchers map damaged connections in Phineas Gage's brain

2012-05-18
Poor Phineas Gage. In 1848, the supervisor for the Rutland and Burlington Railroad in Vermont was using a 13-pound, 3-foot-7-inch rod to pack blasting powder into a rock when he triggered an explosion that drove the rod through his left cheek and out of the top of his head. As reported at the time, the rod was later found, "smeared with blood and brains." Miraculously, Gage lived, becoming the most famous case in the history of neuroscience — not only because he survived a horrific accident that led to the destruction of much of his left frontal lobe but also because ...

1,000 years of climate data confirms Australia's warming

2012-05-18
In the first study of its kind in Australasia, scientists have used 27 natural climate records to create the first large-scale temperature reconstruction for the region over the last 1000 years. The study was led by researchers at the University of Melbourne and used a range of natural indicators including tree rings, corals and ice cores to study Australasian temperatures over the past millennium and compared them to climate model simulations. Lead researcher, Dr Joelle Gergis from the University of Melbourne said the results show that there are no other warm periods ...

Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO

2012-05-18
Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago. Highlights of Mount Sinai research at ASCO: Age, Race, Lower Income, and Lack of Insurance Are Associated with Non-Treatment of Patients With Late-Stage Cancer (Abstract #6065, Monday, June 4, 2012, 1:15 PM-5:15 PM CT, S Hall A2) Mount ...

Navy pilot training enhanced by AEMASE 'smart machine' developed at Sandia Labs

2012-05-18
ALBUQUERQUE, N.M. — Navy pilots and other flight specialists soon will have a new "smart machine" installed in training simulators that learns from expert instructors to more efficiently train their students. Sandia National Laboratories' Automated Expert Modeling & Student Evaluation (AEMASE, pronounced "amaze") is being provided to the Navy as a component of flight simulators. Components are now being used to train Navy personnel to fly H-60 helicopters and a complete system will soon be delivered for training on the E-2C Hawkeye aircraft, said Robert G. Abbott, a Sandia ...

Pollination with precision: How flowers do it

Pollination with precision: How flowers do it
2012-05-18
PROVIDENCE, R.I. [Brown University] — Next Mother's Day, say it with an evolved model of logistical efficiency — a flower. A new discovery about how nature's icons of romance manage the distribution of sperm among female gametes with industrial precision helps explain why the delicate beauties have reproduced prolifically enough to dominate the earth. In pollination, hundreds of sperm-carrying pollen grains stick to the stigma suspended in the middle of a flower and quickly grow a tube down a long shaft called a style toward clusters of ovules, which hold two female sex ...

Open heart surgery for kidney disease patients

2012-05-18
Highlight One type of open heart surgery is safer than the other—in terms of both health and survival—for chronic kidney disease patients. Heart disease is the leading cause of death in individuals with chronic kidney disease. Washington, DC (May 17, 2012) — One type of open heart surgery is likely safer than the other for chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Open heart, or coronary artery bypass, surgery can be done two ways: on-pump or off-pump, ...

LAST 30 PRESS RELEASES:

JNM publishes procedure standard/practice guideline for fibroblast activation protein PET

What to do with aging solar panels?

Scientists design peptides to enhance drug efficacy

Collaboration to develop sorghum hybrids to reduce synthetic fertilizer use and farmer costs

Light-activated ink developed to remotely control cardiac tissue to repair the heart

EMBARGOED: Dana-Farber investigators pinpoint keys to cell therapy response for leukemia

Surgeon preference factors into survival outcomes analyses for multi- and single-arterial bypass grafting

Study points to South America – not Mexico – as birthplace of Irish potato famine pathogen

VR subway experiment highlights role of sound in disrupting balance for people with inner ear disorder

Evolution without sex: How mites have survived for millions of years

U. of I. team develops weight loss app that tracks fiber, protein content in meals

Progress and challenges in brain implants

City-level sugar-sweetened beverage taxes and changes in adult BMI

Duration in immigration detention and health harms

COVID-19 pandemic and racial and ethnic disparities in long-term nursing home stay or death following hospital discharge

Specific types of liver immune cells are required to deal with injury

How human activity has shaped Brazil Nut forests’ past and future

Doctors test a new way to help people quit fentanyl 

Long read sequencing reveals more genetic information while cutting time and cost of rare disease diagnoses

AAAS and ASU launch mission-driven collaborative to strengthen scientific enterprise

Medicaid-insured heart transplant patients face higher risk of post-transplant complications

Revolutionizing ammonia synthesis: New iron-based catalyst surpasses century-old benchmark

A groundbreaking approach: Researchers at The University of Texas at San Antonio chart the future of neuromorphic computing

Long COVID, Italian scientists discovered the molecular ‘fingerprint’ of the condition in children's blood

Battery-powered electric vehicles now match petrol and diesel counterparts for longevity

MIT method enables protein labeling of tens of millions of densely packed cells in organ-scale tissues

Calculating error-free more easily with two codes

Dissolving clusters of cancer cells to prevent metastases

A therapeutic HPV vaccine could eliminate precancerous cervical lesions

Myth busted: Healthy habits take longer than 21 days to set in

[Press-News.org] The downside of corporate dominance